GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestial Biolabs Ltd (BOM:532871) » Definitions » Operating Margin %

Celestial Biolabs (BOM:532871) Operating Margin % : -101.36% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Celestial Biolabs Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Celestial Biolabs's Operating Income for the three months ended in Dec. 2023 was ₹-0.37 Mil. Celestial Biolabs's Revenue for the three months ended in Dec. 2023 was ₹0.37 Mil. Therefore, Celestial Biolabs's Operating Margin % for the quarter that ended in Dec. 2023 was -101.36%.

The historical rank and industry rank for Celestial Biolabs's Operating Margin % or its related term are showing as below:

BOM:532871' s Operating Margin % Range Over the Past 10 Years
Min: -369.65   Med: 8.97   Max: 28.81
Current: -369.65


BOM:532871's Operating Margin % is not ranked
in the Biotechnology industry.
Industry Median: -168.39 vs BOM:532871: -369.65

Celestial Biolabs's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Celestial Biolabs's Operating Income for the three months ended in Dec. 2023 was ₹-0.37 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-2.77 Mil.


Celestial Biolabs Operating Margin % Historical Data

The historical data trend for Celestial Biolabs's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestial Biolabs Operating Margin % Chart

Celestial Biolabs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.74 -20.10 - -249.56 -339.66

Celestial Biolabs Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -194.26 -449.70 -629.47 -101.36

Competitive Comparison of Celestial Biolabs's Operating Margin %

For the Biotechnology subindustry, Celestial Biolabs's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celestial Biolabs's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celestial Biolabs's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Celestial Biolabs's Operating Margin % falls into.



Celestial Biolabs Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Celestial Biolabs's Operating Margin % for the fiscal year that ended in Mar. 2023 is calculated as

Operating Margin %=Operating Income (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=-5.73 / 1.687
=-339.66 %

Celestial Biolabs's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-0.373 / 0.368
=-101.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celestial Biolabs  (BOM:532871) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Celestial Biolabs Operating Margin % Related Terms

Thank you for viewing the detailed overview of Celestial Biolabs's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Celestial Biolabs (BOM:532871) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 59, Road No 12, TSIIC Tech Park, IDA Nacharam, Hyderabad, TG, IND, 500076
Celestial Biolabs Ltd is an India based biopharmaceutical company. It is engaged in the business activity producing and supplying of the biotechnological products. The company offers herbal, feed supplement and nutraceutical products. The proprietary herbal products of the group include BIOVITA, CADALMIN GAE, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, BIOPOWER GOLD, BIO-DNORM, DERMACEL, GYNOCEL, HEALTHONE, RELIFIN, and C-KAPS. The organization formulates and manufactures Ayurvedic proprietary products for the Indian market.

Celestial Biolabs (BOM:532871) Headlines

No Headlines